Ortodontide Botulinum Toksinin Yeri

Erbguth FJ. Historical notes on botulism, Clostridium botulinum, botulinum toxin, and the idea of the therapeutic use of the toxin. MovDisord 2004; 19 (8): 2-6.

Tosun T. Dişhekimliğinde Botulinum toksinlerinin kullanımı: Bruxism ve Gummy Smile tedavilerinde Botox. 2010

Burgen Asv, Dickens F, Zatman Lj.. The action of botulinum toxin on the neuro-muscular junction. The Journal of Physiology, 1949 109(1-2): 10.

Scott AB. Botulinum toxin injection into extraocular muscles as an alternative to strabismus surgery. Ophthalmology. 1980; 87 (10):1044-9.

Scott AB. Botulinum toxin injection of eye muscles to correct strabismus. Trans Am Ophthalmol Soc. 1981; 79:734-70.

Clark RP, Berris CE. Botulinum toxin: a treatment for facial asymmetry caused by facial nerve paralysis. Plast Reconstr Surg. 1989;84(2):353-5.

Carruthers JA. Treatment of glabellar frown lines with C. botulinum-A exotoxin. J Dermatol Surg Oncol. 1992;18(1):17-21.

Durmazlar-Kartal SP, Eskioğlu F. Botulinum Toxin (Fundamentals Before Practice): Review. Turkiye Klinikleri Journal of MedicalSciences 2009; 29 (3): 705.

Huang, W., J.A. Foster, and A.S. Rogachefsky, Pharmacology of botulinum toxin. J Am Acad Dermatol, 2000. 43(2 Pt 1): p. 249-59.

Mênchau A, Bhatia K. Uses of botulinum toxin injection in medicine today, BMJ, 2000; 320: 161-65.

Balanta-melo, J., Toro-ibacache, V., Kupczi̇k, K., & Buvi̇ni̇C, S. Mandibular Bone Loss after Masticatory Muscles Intervention with Botulinum Toxin: An Approach from Basic Research to Clinical Findings. Toxins, 2019: 11(2),

Savrun,F. Botulinum Toksini: Tarihçe, Etki Mekanizması, Uygulama, Terapötik Kullanımı.Nöropsikiyatri Arşiyi 2010; (47): 1-5.

Durmazlar-Kartal SP, Eskioğlu F. Botulinum Toxin (Fundamentals Before Practice): Review. Turkiye Klinikleri Journal of MedicalSciences 2009; 29 (3): 702.

Klein AW, Glogau RG. Botulinum toxin: beyond cosmesis. Arch Dermatol. 2000;136(4):539-41.

Burgen Asv, Dickens F, Zatman Lj. The action of botulinum toxin on the neuro-muscular junction. The Journal of Physiology, 1949 109(1-2): 10.

Hambleton P. Clostridium botulinum toxins: a general review of involvement in disease, structure, mode of action and preparation for clinical use. J Neurol 1992; 239 (1): 16 20.

Baysal V, Yıldırım M. Botulinum toksini ve dermatolojide kullanımı.Türkderm 2002; 36 (2): 92-96

Benedetto AV. The cosmetic uses of Botulinum toxin type A. Int J Dermatol. 1999;38(9):641-55.

Brin MF. Botulinum toxin: chemistry, pharmacology, toxicity, and immunology. Muscle Nerve Suppl. 1997;6 :146-68.

Polo M. Botulinum toxintype A (Botox) for the neuromuscular correction of excessive gingival display on smiling (gummysmile). Am J OrthodDentofacialOrthop 2008; 133 (2): 195-203.

Mezaki T, Kaji R, Kohara N, Fujii H, Katayama M, Shimizu T, et al. Comparison of Therapeutic Efficacies of Type A and F Botulinum Toxins for Blepharospasm A double-blind, controlled study. Neurology. 1995;45(3):506-8.

Munchau A, Bhatia KP. Uses of botulinum toxin injection in medicine today. BMJ. 2000;320(7228):161-5.

Kim HS, Hwang JH, Jeong ST, Lee YT, Lee PK, Suh YL, et al. Effect of muscle activity and botulinum toxin dilution volume on muscle paralysis. Dev Med Child Neurol. 2003;45(3):200-6.

Kocaelli H, Çakarer S, Yaltırık M. Botulinum Toksini (BTX) ve Klinik Kullanımı. GÜ Diş Hek Fak Dergisi. 2004;38(3-4).

Lİ, M., Goldberger, B. A., & Hopki̇ns, C. Fatal case of BOTOX- related anaphylaxis. Journal of forensic sciences, 2005; 50(1), 169–172

Özdemir E, Şanlı H. Theuse of botulinum toxin in dermatology. Turkiye Klinikleri Journalof Dermatology 2002; 12 (3): 174-180.

Dutton JJ. Botulinum-A toxin in the treatment of craniocervical muscle spasms: short-and long-term, local and systemic effects. Survey of ophthalmology. 1996;41(1):51-65.

Polo M. Botulinum toxintype A (Botox) for the neuromuscular correction of excessive gingival display on smiling (gummysmile). Am J OrthodDentofacialOrthop 2008; 133 (2): 195-203.

Suh YJ, Nahm DS, Choi JY, Baek SH. Differential diagnosis for inappropriate upper incisal display during posed smile: contribution of soft tissue and underlying hard tissue. J CraniofacSurg 2009; 20 (6): 2006-2012.

Farista S, Yeltiwar R, Kalakonda B, et al. Laser-assisted lip repositioning surgery: novel approach to treat gummy smile. J Indian Soc Periodontol 2017; 21(2):165–168.

Deepthi K, Yadalam U, Ranjan R, et al. Lip repositioning, an alternative Treatment of gummy smile–-a case report. J Oral Biol Craniofac Res 2018; 8:231–232

Seher BADUR, Serkan SARIDAĞ, Di̇ş Eti̇ Gülümsemesi̇ni̇n Tedavi̇si̇nde Botuli̇num Toksi̇n Uygulaması: 2 Olgu Sunumu Aydın Dental Journal, 2021; 7(1), 95-104

Foudah M. Lip repositioning: an alternative to invasive surgery a 4 year follow up case report. Saudi Dent J 2019; 31:78–84.

Polo M. Botulinum toxin type A in the treatment of excessive gingival display. Am J Orthod Dentofacial Orthop 2005; 127 (2): 214-218.

Mazzuco R, Hexsel D. Gummysmile and botulinum toxin: a new approach based on the gingival exposure area. J AmAcadDermatol 2010; 63 (6): 1042-1051.

Hwang WS, Hur MS, Hu KS, Song WC, Koh KS, Baik HS, et al. Surface anatomy of the lip elevator muscles for the treatment of gummy smile using botulinum toxin. Angle Orthod. 2009 Jan;79(1):70–7.

Chagas TF, Almeida NV de, Lisboa CO, Ferreira DMTP, Mattos CT, Mucha JN. Duration of effectiveness of Botulinum toxin type A in excessive gingival display: a systematic review and meta-analysis. Braz Oral Res. 2018;32.

Nayyar P, Kumar P, Nayyar PV, Singh A. BOTOX: Broadening the Horizon of Dentistry. J Clin Diagn Res. 2014;8: 25-29.

Park KS, Lee CH, Lee JW. JDentAnesthPainMed. 2016 Sep;16(3):151-157.

Srivastava S, Kharbanda S, Pal US, Shah V. Applications of botulinum toxin in dentistry: A comprehensive review. Natl J MaxillofacSurg. 2015; Jul-Dec;6(2):152-9.

Clark GT. The management of oromandibular motor disorders and facial spasms with injections of botulinum toxin. PhysMedRehabilClin North Am. 2003;14(4):727-48.

Boris B, Aren F, Andrew B. Botulinum toxin treatmentof temporomandibuler disorders masseteric hypertrophy and cosmetic masseter reduction. Operative techniques in otolayngology- head and neck surgery. 2004;15 110-3

Yu CC,Chen PKT,Chen YR. Botulinum Toxin A for Lower Facial Contouring : A prospective Study.Aesth Plast Surg 2007; 31: 445-51)

Schwartz M, Freund B. Treatment of temporomandibular disorders with botulinum toxin.Clin J Pain., 2002; 18(6):198-203.

Freund BJ, Schwartz M Intramuscular injection of botulinum toxin as an adjunct to arthrocentesis of the temporomandibular joint: preliminary observations. Br J Oral Maxillofac Surg., 2003; 41(5):351-2.

Tan EK, Jankovic J. Botulinum toxin A in patients with oromandibular dystonia: Long-termfollow-up. Neurology. 1999;53(9):2102-07.

Sinha A, HurakadliM, Yadav P. Botox and derma fillers: The twin face of cosmetic dentistry. Int J Contemp Dent Med Rev. 2015

Umstadt HE., Botulinumtoxin in oromaxillofacialsurgery. MundKieferGesichtschir 2002; 6 (4): 249-260.

Freund B, Schwartz M, Symington JM. Botulinum toxin: new treatment for temporomandibular disorders. Br J Oral Maxillofac Surg 2000; 38 (5): 466-471.

Freund B, Schwartz M. Treatment of chronic cervical associated headache with botulinum toxin A: a pilot study. Headache 2000; 40 (3): 231-236.

Fu KY, Chen HM, Sun ZP, Zhang ZK, Ma XC. Long term efficacy of botulinum toxin type A for the treatment of habitual dislocation of the temporomandibular joint. Br J Oral Maxillofac Surg 2010; 48 (4): 281-284.

Strausz T, Ahlberg J, Lobbezoo F, Restrepo CC, Hublin C, Ahlberg K, Könönen M. Awareness of tooth grinding and clenching from adeloscence to young adulthood: a nine year follow-up. Journal of Oral Rehabilitation 2010;37.497-500

Lobbezoo F, Ahlberg J, Raphael KG, Wetselaar P, Glaros AG, Kato T, Santiago V, Winocur E, De Laat A, De Leeuw R, et al. International consensus on the assessment of bruxism: report of a work in progress. J Oral Rehabil. 2018; 45(11):837–844.

Kim HJ, Yum KW, Lee SS, Heo MS, Seo K. Effects of botulinum toxin type A on bilateral masseteric hypertrophy evaluated with computed tomographic measurement. Dermatol Surg. 2003; 29:484-490.

Van Zandijcke M, Marchau MM. Treatment of bruxism with botulinum toxin injections. J Neurol Neurosurg Psychiatry. 1990;53(6):530.

Bolayir G, Bolayir E, Coşkun A Botulinum toksin type-A practicee in bruksizm cases. Neurol Phychial Br 2005; 12: 43-5

Sener HO, Oral N, Keyf F, Intramasseteric botulinum toxin injection is as effective as overnight splint in nocturnal bruxism.Cephalalgia 2007;27:1191

Kumar A, Spivakovsky S. Bruxism- is botulinum toxin an effective treatment? Evid Based Dent. 2018;19(2):59.

Dursun R, Tanır S. Botulinum toksininin kozmetik uygulamaları. Ertam Sağduyu İ, editör. Her Yönüyle Botulinum Toksin Uygulamalarına Yeniden Bakış. 1. Baskı. Ankara: Türkiye Klinikleri; 2019,14-30.

Asutay F., Atalay Y., Asutay H., Acar A.H. The Evaluation of the Clinical Effects of Botulinum Toxin on Nocturnal Bruxism. Pain Res. Manag. 2017;2017: 6264146.

Shehri Z.G., Alkhouri I., Hajeer M.Y., Haddad I., Abu Hawa M.H. Evaluation of the Efficacy of Low-Dose Botulinum Toxin Injection Into the Masseter Muscle for the Treatment of Nocturnal Bruxism: A Randomized Controlled Clinical Trial. Cureus. 2022;14: e32180.

Mkhitaryan L., Alcolea J.M. Prospective Clinical Study and Ultrasound Assessment in Patients with Bruxism Treated with Botulinum Toxin. Aesthetic Med. 2020;6:25–34.

Da Silva Ramalho J.A., Palma L.F., Ramalho K.M., Tedesco T.K., Morimoto S. Effect of Botulinum Toxin A on Pain, Bite Force, and Satisfaction of Patients with Bruxism: A Randomized Single-Blind Clinical Trial Comparing Two Protocols. Saudi Dent. J. 2023;35:53–60.

Dressler D, Benecke R. Autonomic side effects of botulinum toxin type B treatment of cervical dystonia and hyperhidrosis. European Neurology, 2003; 49(1): 34-38.

Yiannakopoulou E. Serious and long-term adverse events associated with the therapeutic and cosmetic use of botulinum toxin. Pharmacology. 2015;95(1-2):65-9.

Cosmetic Plastic Surgery Research: 2009 News Release. http://www.cosmeticplastic- surgerystatistics.com (accessed May 15, 2011).

Eleopra R, Tunogli V, Canatti L, et al: Botuli- num toxin treatment in the facial muscles in humans: evidence of an action in untreated near muscles by peripheral local diffusion. Neurology 1996; 46:1158–1160. 68.Yaraskavitch M, Leonard T, Herzog W: Botox produces functional weakness in non-inject- ed muscles adjacent to the target muscle. J Biomech 2008; 41:897–902.

Curra A, Berardelli A: Do the unintended ac- tions of botulinum toxin at distant sites have clinical implications? Neurology 2009;72: 1095–1099.